---
tags:
  - iints/source
  - iints/source/consensus
source_id: "attd_2019_time_in_range"
source_bucket: "packaged_evidence"
category: "consensus"
component: "metrics_targets"
url: "https://doi.org/10.2337/dci19-0028"
doi: "10.2337/dci19-0028"
status: active
---

# Clinical Targets for Continuous Glucose Monitoring Data Interpretation

> [!info] What this source supports
> Basis for TIR/TBR/TAR interpretation in analytics and scorecards.

| Field | Value |
| --- | --- |
| Source ID | `attd_2019_time_in_range` |
| Bucket | `packaged_evidence` |
| Category | `consensus` |
| SDK component | `metrics_targets` |
| DOI | 10.2337/dci19-0028 |
| URL | https://doi.org/10.2337/dci19-0028 |
| Origin file | `src/iints/presets/evidence_sources.yaml` |

## Citation

Battelino T, Danne T, Bergenstal RM, et al. Diabetes Care. 2019;42(8):1593-1603.

## User Interpretation

Use this source to explain **why the SDK default, metric, dataset, or hardware-safety boundary exists**. It is evidence support for pre-clinical simulation and documentation, not a medical approval claim.
